PHARMAMAR HA ACTUALIZADO FASE III LAGOON LURBINECTEDIN Y SE RETRASA SU CONCLUSIÓN HASTA ABRIL 2026.
08 junio 2020
Wall Street Os Positive on Jazz Pharmaceuticals PLC (JAZZ). On Average, Analysts Give JAZZ a Strong Buy Rating. The Average Price Target is $160.571, Which Means Analysts Expect the Stock to Rise by 40.94% Over the Next Twelve Months .
Entrada más reciente
Entrada antigua
Inicio